Article
Antioxidant MitoQ increases viability of human corneal endothelial cells with congenital hereditary endothelial dystrophy-associated SLC4A11 mutations.
Ophthalmic genetics - 1 Apr 2025
Peshkar-Kulkarni Saloni, Chung Doug D, Aldave Anthony J
Abstract excerpt
PURPOSE: To assess the impact of MitoQ, a mitochondria-targeted antioxidant, on viability of human corneal endothelial cell (hCEnC) lines expressing SLC4A11 mutations associated with congenital hereditary endothelial dystrophy (CHED) and Fuchs endothelial corneal dystrophy type 4 (FECD4). METHODS: SLC4A11 wildtype (SLC4A11WT) and mutant (SLC4A11MU) hCEnC lines were created to express either SLC4A11 variant 2 (V2)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
